EVOTEC’S TRANSLATIONAL BRIDGE beLAB1407 AWARDS PROJECT FROM DUNDEE UNIVERSITY
Hamburg, Germany, 1 August 2022:
- PROJECT ORIGINATES FROM DR IGNACIO MORAGA’S LAB AND FOCUSES ON INFLAMMATORY DISORDERS
- BELAB1407 IS A TRANSLATIONAL BRIDGE COLLABORATION BETWEEN EVOTEC, BRISTOL MYERS SQUIBB AND UK UNIVERSITIES
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that after a successful call for proposals, University of Dundee has been awarded its first funding within the beLAB1407 BRIDGE initiative. beLAB1407 is a translational BRIDGE collaboration between Evotec and Bristol Myers Squibb, aiming to accelerate translational research from the UK’s academic life science ecosystem.